1.58
price up icon1.28%   0.02
after-market After Hours: 1.55 -0.03 -1.90%
loading
Repare Therapeutics Inc stock is traded at $1.58, with a volume of 221.56K. It is up +1.28% in the last 24 hours and up +13.67% over the past month. Repare Therapeutics Inc is a precision medicine oncology company focused on the development of synthetic lethality-based therapies for patients with cancer. The Company's focus is the research, development and commercialization of precision oncology drugs targeting specific vulnerabilities of tumors in genetically defined patient populations.
See More
Previous Close:
$1.56
Open:
$1.57
24h Volume:
221.56K
Relative Volume:
0.69
Market Cap:
$67.77M
Revenue:
$51.13M
Net Income/Loss:
$-93.80M
P/E Ratio:
-0.7085
EPS:
-2.23
Net Cash Flow:
$-129.10M
1W Performance:
+5.33%
1M Performance:
+13.67%
6M Performance:
+37.39%
1Y Performance:
-59.90%
1-Day Range:
Value
$1.56
$1.62
1-Week Range:
Value
$1.5005
$1.62
52-Week Range:
Value
$0.89
$4.22

Repare Therapeutics Inc Stock (RPTX) Company Profile

Name
Name
Repare Therapeutics Inc
Name
Phone
(857) 412-7018
Name
Address
7171 FREDERICK BANTING, SAINT-LAURENT, QC
Name
Employee
129
Name
Twitter
@reparerx
Name
Next Earnings Date
2023-08-09
Name
Latest SEC Filings
Name
RPTX's Discussions on Twitter

Compare RPTX with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
RPTX
Repare Therapeutics Inc
1.58 66.91M 51.13M -93.80M -129.10M -2.23
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
460.83 120.60B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
558.63 60.80B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
324.79 42.87B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
595.19 36.23B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
294.51 31.54B 3.81B -644.79M -669.77M -6.24

Repare Therapeutics Inc Stock (RPTX) Upgrades & Downgrades

Date Action Analyst Rating Change
Jun-09-23 Upgrade Stifel Hold → Buy
Feb-03-23 Downgrade Morgan Stanley Overweight → Equal-Weight
Jan-06-23 Initiated CapitalOne Overweight
Apr-12-22 Downgrade Stifel Buy → Hold
Mar-17-22 Resumed Goldman Buy
Sep-23-21 Initiated Stifel Buy
Sep-13-21 Initiated H.C. Wainwright Buy
Jun-28-21 Initiated Guggenheim Buy
Mar-01-21 Initiated Berenberg Buy
Oct-28-20 Initiated Northland Capital Outperform
Jul-14-20 Initiated Cowen Outperform
Jul-14-20 Initiated Goldman Neutral
Jul-14-20 Initiated Morgan Stanley Overweight
Jul-14-20 Initiated Piper Sandler Overweight
View All

Repare Therapeutics Inc Stock (RPTX) Latest News

pulisher
09:56 AM

How many analysts rate Repare Therapeutics Inc. as a “Buy”Market-beating returns - jammulinksnews.com

09:56 AM
pulisher
08:19 AM

Pattern recognition hints at Repare Therapeutics Inc. upsideFree News Based Entry Opportunity Alerts - Newser

08:19 AM
pulisher
08:13 AM

Will Repare Therapeutics Inc. benefit from macro trendsTrade Safety Report with Pattern Insights - Newser

08:13 AM
pulisher
07:33 AM

Best data tools to analyze Repare Therapeutics Inc. stockValue Investing Summary and Earnings Outlook - Newser

07:33 AM
pulisher
07:27 AM

Quantitative breakdown of Repare Therapeutics Inc. recent moveLong-Term Investment Strategy Impact Analysis - Newser

07:27 AM
pulisher
07:05 AM

Can Repare Therapeutics Inc. hit a new high this monthEquity Forecast with Predictive AI Screener - Newser

07:05 AM
pulisher
04:54 AM

How high can Repare Therapeutics Inc. stock go Strong Buy Signal Summary with Entry Zone - Newser

04:54 AM
pulisher
12:58 PM

Repare Therapeutics (NASDAQ:RPTX) Trading 0.6% HigherHere's What Happened - MarketBeat

12:58 PM
pulisher
Jul 27, 2025

What are the technical indicators suggesting about Repare Therapeutics Inc.Consistently high yield - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

What are Repare Therapeutics Inc. company’s key revenue driversInvest smarter with comprehensive market analysis - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

How strong is Repare Therapeutics Inc. company’s balance sheetDiscover dynamic stocks ready to soar - jammulinksnews.com

Jul 27, 2025
pulisher
Jul 27, 2025

Is Repare Therapeutics Inc. Stock a Good Fit for Conservative InvestorsFree Exclusive Group - Newser

Jul 27, 2025
pulisher
Jul 27, 2025

ARK Investment Management LLC Sells 875,514 Shares of Repare Therapeutics Inc. (NASDAQ:RPTX) - MarketBeat

Jul 27, 2025
pulisher
Jul 27, 2025

How Repare Therapeutics Inc. stock performs during market volatilityLow Risk Trading Ideas - Newser

Jul 27, 2025
pulisher
Jul 26, 2025

Repare Therapeutics (NASDAQ:RPTX) Trading 0.6% Higher – What’s Next? - Defense World

Jul 26, 2025
pulisher
Jul 25, 2025

Is Repare Therapeutics Inc. a good long term investmentMassive portfolio appreciation - PrintWeekIndia

Jul 25, 2025
pulisher
Jul 25, 2025

Will Repare Therapeutics Inc. stock benefit from interest rate changesExplosive earnings growth - jammulinksnews.com

Jul 25, 2025
pulisher
Jul 25, 2025

Why Repare Therapeutics Inc. stock is on top investor watchlistsUnrivaled growth potential - jammulinksnews.com

Jul 25, 2025
pulisher
Jul 25, 2025

What analysts say about Repare Therapeutics Inc. stock outlookMarket-leading growth rates - jammulinksnews.com

Jul 25, 2025
pulisher
Jul 24, 2025

What drives Repare Therapeutics Inc. stock priceFree Wealth Planning Blueprint - Autocar Professional

Jul 24, 2025
pulisher
Jul 22, 2025

What analysts say about Repare Therapeutics Inc. stockPowerful growth strategies - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

Why Repare Therapeutics Inc. stock attracts strong analyst attentionFree Access to Community - Newser

Jul 22, 2025
pulisher
Jul 22, 2025

Repare Therapeutics Inc. Stock Analysis and ForecastUnprecedented growth rates - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 19, 2025

what makes repare therapeutics inc. stock price move sharplyLow Risk Profit Ideas - Newser

Jul 19, 2025
pulisher
Jul 18, 2025

Layoff Tracker: Following Challenges With DMD Therapy, Sarepta Will Cut 500 Employees - BioSpace

Jul 18, 2025
pulisher
Jul 16, 2025

Repare Therapeutics Jumps 15% After $10M Licensing Deal With Debiopharm - Yahoo Finance

Jul 16, 2025

Repare Therapeutics Inc Stock (RPTX) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading

Repare Therapeutics Inc Stock (RPTX) Insider Trading

Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total
Zinda Michael
EVP, CHIEF SCIENTIFIC OFFICER
Mar 12 '25
Sale
1.14
5,611
6,397
80,297
Forte Steve
EVP, CHIEF FINANCIAL OFFICER
Mar 12 '25
Sale
1.14
6,884
7,848
54,786
Segal Lloyd Mitchell
PRESIDENT AND CEO
Mar 12 '25
Sale
1.14
21,179
24,144
124,394
$23.09
price down icon 1.32%
$37.06
price up icon 1.06%
$101.75
price down icon 2.12%
$27.45
price down icon 4.26%
$112.79
price down icon 2.19%
biotechnology ONC
$294.51
price up icon 1.04%
Cap:     |  Volume (24h):